vs

Side-by-side financial comparison of Labcorp (LH) and W. R. Berkley Corporation (WRB). Click either name above to swap in a different company.

W. R. Berkley Corporation is the larger business by last-quarter revenue ($3.7B vs $3.5B, roughly 1.0× Labcorp). W. R. Berkley Corporation runs the higher net margin — 14.0% vs 7.9%, a 6.1% gap on every dollar of revenue. On growth, Labcorp posted the faster year-over-year revenue change (5.8% vs 4.0%). Over the past eight quarters, W. R. Berkley Corporation's revenue compounded faster (5.5% CAGR vs 4.8%).

Labcorp is a leading global life sciences and diagnostic testing firm that offers comprehensive clinical laboratory services, drug development support, and medical testing solutions for healthcare providers, pharmaceutical companies, and individual patients. It uses advanced scientific expertise and innovative technologies to deliver accurate, actionable health insights that support clinical decisions, accelerate new treatment development, and improve patient health outcomes globally.

William Robert Berkley is the founder and current chairman of W. R. Berkley Corporation and the chairman of the New York University Board of Trustees.

LH vs WRB — Head-to-Head

Bigger by revenue
WRB
WRB
1.0× larger
WRB
$3.7B
$3.5B
LH
Growing faster (revenue YoY)
LH
LH
+1.7% gap
LH
5.8%
4.0%
WRB
Higher net margin
WRB
WRB
6.1% more per $
WRB
14.0%
7.9%
LH
Faster 2-yr revenue CAGR
WRB
WRB
Annualised
WRB
5.5%
4.8%
LH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
LH
LH
WRB
WRB
Revenue
$3.5B
$3.7B
Net Profit
$277.8M
$515.2M
Gross Margin
28.7%
Operating Margin
10.8%
Net Margin
7.9%
14.0%
Revenue YoY
5.8%
4.0%
Net Profit YoY
30.5%
EPS (diluted)
$3.35
$1.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LH
LH
WRB
WRB
Q1 26
$3.5B
$3.7B
Q4 25
$3.5B
$3.7B
Q3 25
$3.6B
$3.8B
Q2 25
$3.5B
$3.7B
Q1 25
$3.3B
$3.5B
Q4 24
$3.3B
$3.7B
Q3 24
$3.3B
$3.4B
Q2 24
$3.2B
$3.3B
Net Profit
LH
LH
WRB
WRB
Q1 26
$277.8M
$515.2M
Q4 25
$164.7M
$449.5M
Q3 25
$261.1M
$511.0M
Q2 25
$237.9M
$401.3M
Q1 25
$212.8M
$417.6M
Q4 24
$143.4M
$576.1M
Q3 24
$169.3M
$365.6M
Q2 24
$205.3M
$371.9M
Gross Margin
LH
LH
WRB
WRB
Q1 26
28.7%
Q4 25
28.2%
Q3 25
28.8%
Q2 25
29.7%
Q1 25
28.3%
Q4 24
26.9%
Q3 24
27.6%
Q2 24
28.8%
Operating Margin
LH
LH
WRB
WRB
Q1 26
10.8%
Q4 25
7.6%
15.4%
Q3 25
11.1%
17.2%
Q2 25
11.2%
14.2%
Q1 25
9.7%
15.2%
Q4 24
6.5%
19.9%
Q3 24
7.7%
14.0%
Q2 24
9.2%
14.7%
Net Margin
LH
LH
WRB
WRB
Q1 26
7.9%
14.0%
Q4 25
4.7%
12.1%
Q3 25
7.3%
13.6%
Q2 25
6.7%
10.9%
Q1 25
6.4%
11.8%
Q4 24
4.3%
15.7%
Q3 24
5.2%
10.8%
Q2 24
6.4%
11.2%
EPS (diluted)
LH
LH
WRB
WRB
Q1 26
$3.35
$1.31
Q4 25
$1.98
$1.13
Q3 25
$3.12
$1.28
Q2 25
$2.84
$1.00
Q1 25
$2.52
$1.04
Q4 24
$1.72
$0.89
Q3 24
$2.00
$0.91
Q2 24
$2.43
$0.92

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LH
LH
WRB
WRB
Cash + ST InvestmentsLiquidity on hand
$981.1M
$2.1B
Total DebtLower is stronger
$5.8B
Stockholders' EquityBook value
$8.7B
Total Assets
$19.1B
$44.3B
Debt / EquityLower = less leverage
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LH
LH
WRB
WRB
Q1 26
$981.1M
$2.1B
Q4 25
$532.3M
$2.5B
Q3 25
$598.1M
$2.4B
Q2 25
$647.3M
$2.0B
Q1 25
$369.4M
$1.7B
Q4 24
$1.5B
$2.0B
Q3 24
$1.5B
$1.6B
Q2 24
$265.1M
$1.6B
Total Debt
LH
LH
WRB
WRB
Q1 26
$5.8B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
LH
LH
WRB
WRB
Q1 26
$8.7B
Q4 25
$8.6B
$9.7B
Q3 25
$8.7B
$9.8B
Q2 25
$8.5B
$9.3B
Q1 25
$8.3B
$8.9B
Q4 24
$8.1B
$8.4B
Q3 24
$8.2B
$8.4B
Q2 24
$8.0B
$7.8B
Total Assets
LH
LH
WRB
WRB
Q1 26
$19.1B
$44.3B
Q4 25
$18.4B
$44.1B
Q3 25
$18.3B
$43.7B
Q2 25
$18.1B
$42.7B
Q1 25
$17.6B
$41.3B
Q4 24
$18.4B
$40.6B
Q3 24
$18.6B
$40.4B
Q2 24
$16.7B
$38.9B
Debt / Equity
LH
LH
WRB
WRB
Q1 26
0.67×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LH
LH
WRB
WRB
Operating Cash FlowLast quarter
$191.5M
Free Cash FlowOCF − Capex
$70.5M
FCF MarginFCF / Revenue
2.0%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
0.69×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LH
LH
WRB
WRB
Q1 26
$191.5M
Q4 25
$614.2M
$995.1M
Q3 25
$387.2M
$1.1B
Q2 25
$620.6M
$703.8M
Q1 25
$18.5M
$743.8M
Q4 24
$777.2M
$810.0M
Q3 24
$277.3M
$1.2B
Q2 24
$561.1M
$881.3M
Free Cash Flow
LH
LH
WRB
WRB
Q1 26
$70.5M
Q4 25
$490.3M
Q3 25
$280.5M
Q2 25
$542.7M
Q1 25
$-107.5M
Q4 24
$665.1M
Q3 24
$161.5M
Q2 24
$432.9M
FCF Margin
LH
LH
WRB
WRB
Q1 26
2.0%
Q4 25
13.9%
Q3 25
7.9%
Q2 25
15.4%
Q1 25
-3.2%
Q4 24
20.0%
Q3 24
4.9%
Q2 24
13.4%
Capex Intensity
LH
LH
WRB
WRB
Q1 26
3.4%
Q4 25
3.5%
Q3 25
3.0%
Q2 25
2.2%
Q1 25
3.8%
Q4 24
3.4%
Q3 24
3.5%
Q2 24
4.0%
Cash Conversion
LH
LH
WRB
WRB
Q1 26
0.69×
Q4 25
3.73×
2.21×
Q3 25
1.48×
2.23×
Q2 25
2.61×
1.75×
Q1 25
0.09×
1.78×
Q4 24
5.42×
1.41×
Q3 24
1.64×
3.39×
Q2 24
2.73×
2.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LH
LH

Revenues$2.8B78%
Other$775.5M22%

WRB
WRB

Segment breakdown not available.

Related Comparisons